Provided by Tiger Trade Technology Pte. Ltd.

NEUROGENE INC

26.07
-0.4300-1.62%
Volume:339.88K
Turnover:9.26M
Market Cap:521.70M
PE:-5.17
High:29.63
Open:28.90
Low:26.07
Close:26.50
52wk High:43.66
52wk Low:15.93
Shares:20.01M
Float Shares:11.34M
Volume Ratio:1.27
T/O Rate:3.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0440
EPS(LYR):-4.2400
ROE:-45.32%
ROA:-27.97%
PB:2.40
PE(LYR):-6.15

Loading ...

Jennison Associates Llc Reports 11.1% Passive Stake in Neurogene as of Sept 30 - SEC Filing

THOMSON REUTERS
·
Oct 07

Neurogene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Oct 06

Neurogene Grants Inducement Stock Options for 8,340 Shares to Five New Employees

Reuters
·
Oct 06

Neurogene Awards Inducement Stock Options for 38,330 Shares to New Hires

Reuters
·
Sep 05

Neurogene price target raised to $81 from $69 at Guggenheim

TIPRANKS
·
Aug 17

Neurogene price target lowered to $166 from $180 at Canaccord

TIPRANKS
·
Aug 17

Stifel Nicolaus Sticks to Their Buy Rating for Neurogene (NGNE)

TIPRANKS
·
Aug 13

Neurogene Price Target Raised to $81.00/Share from $69.00 by Guggenheim

Dow Jones
·
Aug 12

Annexon Biosciences Q2 Net Loss Widens, Cash Runway Extended

Reuters
·
Aug 12

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

TIPRANKS
·
Aug 12

Savara Q2 Loss Widens as Operating Expenses Rise

Reuters
·
Aug 12

Neurogene Inc : Canaccord Genuity Cuts Target Price to $166 from $180

THOMSON REUTERS
·
Aug 11

Neurogene Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Neurogene Q2 Operating Expenses USD 36.67 Million

Reuters
·
Aug 11

Neurogene Q2 EPS $(1.53) Misses $(1.39) Estimate

Benzinga Earnings
·
Aug 11

Neurogene Publishes Corporate Presentation Highlighting NGN-401 Gene Therapy Program for Rett Syndrome

Reuters
·
Aug 11

Neurogene Q2 Adjusted Loss Per Share Misses Estimates on Employee Costs

Reuters
·
Aug 11

Neurogene Q2 FY26 Net Loss Widens to USD 34.49 Million

Reuters
·
Aug 11

Neurogene Q2 Adjusted EPS USD -1.53 VS. Ibes Estimate USD -1.42

THOMSON REUTERS
·
Aug 11